Cipla Ltd.

Cipla Ltd.

Cipla Ltd.

Overview
Date Founded

1935

Headquarters

Mumbai Central,Mumbai, Maharashtra 400 008

Type of Company

Public

Employees (Worldwide)

35.7K

Industries

Pharmaceuticals
Hospitals & Patient Services
Medical Support Services
Biotechnology

Company Description

Cipla Ltd. engages in the manufacture and distribution of healthcare products and bulk drugs. It operates through the following segments: Pharmaceuticals and New Ventures. The Pharmaceuticals segment develops, manufactures, sells and distributes generic or branded generic medicines as well as active pharmaceutical ingredients. The New Ventures segment includes the operations of the two wholly owned subsidiaries, Cipla Health Ltd., a consumer healthcare company and Cipla BioTec Pvt. Ltd, which is into the business of Biosimilars. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Mumbai, India.

Contact Data
Trying to get in touch with decision makers at Cipla Ltd.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Executive Officer, MD & Director

Global Chief Financial Officer

Chief Executive Officer-India Business

Chief Executive Officer South Africa & Regional Head Africa & Access

Global Chief Scientific Officer

Global Chief People Officer

Global Head of Quality, Medical Affairs & Pharmacovigilance

Chief Executive Officer

Global General Counsel

Chief Internal Auditor

Board of Directors

Former Chief Executive Officer at Cipla Ltd.

Executive Vice Chairperson, Board of Directors at Cipla Ltd.

Reliance Industries Limited

Chief Executive Officer, MD & Director at Cipla Ltd.

Former Executive Director-Marketing at PepsiCo, Inc.

Former Managing Director at Bharat Petroleum Corp. Ltd.

Senior Professional at Cipla Ltd.

Founder at Cipla BioTec Pvt Ltd.

Founder & Director at Joint Clinical Research Centre

Paths to Cipla Ltd.
Potential Connections via
Relationship Science
You
Cipla Ltd.
Owners & Shareholders
Details Hidden

ICICI Prudential AM follows a bottom-up investment approach and base stock selection on the fundamental assessment of companies. The firm seeks to identify investment opportunities by using quantitative models to screen the market. Their research process includes a company visitation program.

Details Hidden

SBI is an active manager which offers portfolios that focuses on Indian securities. Portfolios offered in SBI separately managed accounts may be suitable for a wide variety of investors, but particularly for more conservative investors with long-term time horizons that seeks growth of capital or a high level of current income, investments in sound, well-managed companies that have long-term potential investments gains, and those who wish not to be led by the market’s irrational and emotional behavior and desire an easy-to- understand strategy for investing in the stock and bond markets. The firm may also purchase, recommend and provide advice on investment in fixed rate instruments, foreign securities (particularly Indian securities), money market and other financial instruments, derivative and hybrid instruments and any other interest in any of the foregoing.

Details Hidden

HDFC AMC manages portfolios invested in equity, fixed-income and money-market instruments with a primary focus on Indian securities. They manage a range of investment vehicles including a fixed maturity plan, ETFs, equity and growth funds, debt and income funds, fund of fund schemes, capital protection funds and liquid funds.

Recent Transactions
Details Hidden

Cipla Ltd. purchases Wanbury Ltd. /4 Brands from Wanbury Ltd.

Details Hidden

Cipla Ltd. purchases Cipla Health Ltd. from Eight Roads Ventures India

Details Hidden

Cipla Ltd., Golden Cross Pharma Pvt Ltd. purchase Wellthy Therapeutics Pvt. Ltd.

Transaction Advisors
Legal Advisor

Advised onCipla Ltd., Cipla (EU) Ltd. purchase Invagen Pharmaceuticals, Inc.

Investment Advisor

Advised onBiomab Brilliant Ltd. purchases Biomab Holding Ltd. from Cipla Ltd.

Legal Advisor

Advised onPharmaS doo purchases Cipla Croatia doo from Cipla Ltd.

Co-Chair, Corporate Practice Group

Advised onCipla Ltd., Cipla (EU) Ltd. purchase Invagen Pharmaceuticals, Inc.

Legal Advisor

Advised onCipla Ltd., Cipla (EU) Ltd. purchase Invagen Pharmaceuticals, Inc.

Counsel

Advised onCipla Ltd., Cipla (EU) Ltd. purchase Invagen Pharmaceuticals, Inc.

Advisors & Consultants
Legal Advisor

Partner at Orrick, Herrington & Sutcliffe LLP

Clients

Protek Group is one of the largest pharmaceutical companies of Russia*. The Group has diversified business interests and operates in all major segments of the pharmaceutical industry such as medicine manufacturing, distribution and retail of pharmaceutical, health and beauty products. The Group employs over 12,000 specialists. The Group has a vertically integrated structure, which enables it to set up a complete product supply chain – Manufacturing – Distribution - Retail. The key companies of the Group are CV Protek, a national distributor of pharmaceutical, health and beauty products; Sotex Farm Firm, a medicine manufacturer; and Rigla Pharmacy Chain. The Protek Public Company was set up in 2002, in the course of the Group restructuring process and now is the parent company of the Group that consolidates shares (stocks) in the authorized capital of the affiliated and subsidiary companies. CV Protek is the major distributor of pharmaceutical, health and beaty products in Russia. It has been on the Russian pharmaceutical market since 1990. On the basis of the 2010 performance, CV Protek occupies the first place in the overall ranking of pharmaceutical distributors**. The company supplies medicine to all the 83 constituent territories of the Russian Federation; its total warehouse area, according to the 2010 estimates, is about 159,000 square meters. Rigla Pharmacy Chain comes second in the top list of Russia’s major pharmacy chains according to the sales volume**. The chain boasts 695*** pharmacies in 26 constituent territories. The company promotes pharmacies of two types: Rigla Pharm Markets with an open display, a big variety of products, including pharmaceutical goods, and the Bud Zdorov! discounters with a close display and a big variety of medicine. Sotex Farm Firm is the core of the manufacturing segment. The company’s manufacturing facility, located in the Sergiyev-Posad district of the Moscow Region, produces cartridged injection solutions of liquid INPN generics, other licensed medicine, and its own-brand medicine. The facility is one of the most advanced high-tech pharmaceutical enterprises in Russia. On the basis of the 2010 performance, the company reached the fourth position in the top list of domestic manufacturers according to the wholesale volume***. Protek Group follows modern standards in the financial management. Its core elements include corporate financial reporting in compliance with the International Accounting Standards (IAS), international auditing, well-considered financial policy, and implementation of the Oracle E-Business Suite, an ERP system, in its segments. The Group business practice aims at the increase in the competitive ability, stability of the Group business as a whole, and at the maximum capitalization of each company in the respective market segments. Protek Group runs in a socially significant sector and is committed to socially responsible business practices, in full measure meeting the obligations to its partners, staff and society. The Group provides sponsorship and charitable donations for cultural, historic and research projects, as well as humanitarian assistance. Protek Group mission is the following: "Our goal is to take care of the human beauty and health. We prize economic, social and ethical values of the society, fairly fulfill our commitments to the public, partners and the state, thus setting up high business standards."

DCC Plc provides international sales, marketing, and business support services. It operates through the following segments: DCC LPG, DCC Retail & Oil, DCC Healthcare, and DCC Technology. The DCC LPG segment operates a liquefied petroleum gas (LPG) sales and marketing business with operations in Europe, Asia, and the US with a developing business in the retailing of natural gas and electricity. The DCC Retail & Oil segment is involved in the sales, marketing, and retailing of transport and commercial fuels, heating oils, and related products and services in Europe. The DCC Healthcare segment provides products and services to healthcare providers and health and beauty brand owners. The DCC Technology segment serves as a route-to-market and supply chain partner for global technology brands. The company was founded by Jim Flavin in 1976 and is headquartered in Dublin, Ireland.

PT Kalbe Farma Tbk engages in the development, distribution, and trading of pharmaceutical products. It operates through the following segments: Prescription Pharmaceutical, Consumer Health, Nutritionals, and Distribution and Logistic. The Prescription Pharmaceutical segment offers generic drugs, branded generics, and licensed drugs, which are distributed to hospitals, pharmacies, and drug stores. The Consumer Health segment includes over-the-counter drugs, consumer products, food supplements, preventive products, energy drinks, and healthy ready-to-drink products. The Nutritionals segment sells biscuits, cereals, and milk products for infants, toddlers, children, pre-teenagers, adults, expectant and lactating mothers, and elderly; as well as nutritional products for consumers with special medical needs. The Distribution and Logistic segment maintains distribution of the company's and third party principal's products across Indonesia; and focuses on the trading of raw material, medical devices, and retail health service. The company founded by Boenyamin Setiawan on September 10, 1966 and is headquartered in Jakarta, Indonesia.

Key Stats and Financials As of 2020
Market Capitalization
$8.39B
Total Enterprise Value
$4.69B
Earnings Per Share
$0.25
EBITDAMargin
17.85%
Enterprise Value / Sales
2.11x
Enterprise Value EBITDAOperating
11.8x
TEVNet Income
22.96x
Debt TEV
0.09x
Three Year Compounded Annual Growth Rate Of Revenue
5.81%
Revenue
$2.23B
Net Profit
$204M
EBITDA
$398M
Total Debt
$408M
Total Equity
$2.12B
Five Year Compounded Annual Growth Rate Of Revenue
10.56%
Investments
Details Hidden

Cipla BioTec Pvt Ltd. manufactures pharmaceutical products. It focuses on research, development, manufacturing and marketing of biosimilars, in the fields of cancer, auto-immune diseases, respiratory diseases and diabetes. The firm products include CBT 124, CBT 127 and CBT 128. The company was founded by Khwaja Abdul Hamied in 1935 and is headquartered in Salcette, India.

Details Hidden

Avesthagen Ltd. provides personalized healthcare through convergence of food, pharma and population genetics. It offers genome analysis, transcriptome analysis, metabolome analysis and lead optimization, and recombinant protein expression services, as well as engages in the generation of stable mammalian cell lines over-expressing a recombinant protein, development of product specific bioassays, and design of novel animal component free production media. The company was founded by Villoo Morwala Zareer Patell on April 20, 1998 and is headquartered in Bangalore, India.

Details Hidden

Cipla Quality Chemical Industries Ltd. manufactures and delivering anti-retroviral drugs and artemisinin-based combination therapies. Its products include duovir, duomune, texvir, zentair, and lumartem. The company was founded by Emmanuel Katongole and is headquartered in Kampala, Uganda.

Suppliers
AptarGroup, Inc. Personal Products | Crystal Lake, IL

AptarGroup, Inc. develops manufactures and sales of consumer product dispensing systems. It operates through the following business segments: Beauty & Home, Pharma and Food & Beverage. The Beauty & Home segment primarily sells pumps, aerosol valves and accessories to the personal care and household markets and pumps and decorative components to the fragrance/cosmetic market. The Pharma segment supplies pumps and metered dose inhaler valves to the pharmaceutical market worldwide. The Food & Beverage segment sell dispensing and non-dispensing closures and, to a lesser degree, spray pumps and aerosol valves to the food and beverage markets. The company was founded in 1940 and is headquartered in Crystal Lake, IL.

Blue Star Ltd. Industrial Machinery & Manufacturing | Mumbai, India

Blue Star Ltd. engages in the manufacture, trade, and installation of air conditioning systems. It operates through the following segments: Electro-Mechanical Projects and Packaged Air Conditioning Systems; Unitary Products; and Professional Electronics and Industrial Systems. The Electro-Mechanical Projects and Packaged Air Conditioning Systems segment designs, manufactures, installs, comissions and maintain the central air conditioning plants, packaged and ducted systems and vairable refigerent flow systems, as well as contracting services in electrification, plumbing and fire-fighting. The Unitary Products segment offers a wide variety of air conditioners, water purifiers, air purifiers, air coolers, commercial refrigeration products and cold chain equipment for both residential and commercial applications. The Professional Electronics and Industrial Systems segment manufactures electronic equipment and services, as well as industrial product and systems. The company was founded by Mohan T. Advani in 1943 and is headquartered in Mumbai, India.

Arshiya Ltd. Other Business & Consulting Services | Mumbai, India

Arshiya Ltd. engages in supply chain management and logistic infrastructure solutions. It operates through the following segments: Free Trade and Warehousing/Inland Container Deport, Rail Transport Operations and Domestic Warehousing Zone. The Free Trade and Warehousing/Inland Container Deport segment refers to the operation of container port and warehousing solutions. The Rail Transport Operations segment fixed schedule transportation services and cargo tracking services. The Domestic Warehousing Zone refers to multi-modal logistics park and domestic warehousing facility in NCR at Khurja in the State of Uttar Pradesh. The company was founded by Ajay Shankarlal Mittal on July 3, 1981 and is headquartered in Mumbai, India.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cipla Ltd.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cipla Ltd.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Cipla Ltd..